UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 694

Sortiert nach

Extracellular histones promote thrombin generation through platelet-dependent mechanisms: involvement of platelet TLR2 and TLR4

Blood, 2011-08, Vol.118 (7), p.1952-1961

2011

Volltextzugriff (PDF)

Active tissue factor pathway inhibitor is expressed on the surface of coated platelets

Blood, 2007-03, Vol.109 (5), p.1931-1937

2007

Volltextzugriff (PDF)

Prophylactic rituximab after allogeneic transplantation decreases B-cell alloimmunity with low chronic GVHD incidence

Blood, 2012-06, Vol.119 (25), p.6145-6154

2012

Volltextzugriff (PDF)

X-linked clonality testing: interpretation and limitations

Blood, 2007-09, Vol.110 (5), p.1411-1419

2007

Volltextzugriff (PDF)

Deletion of the alternatively spliced fibronectin EIIIA domain in mice reduces atherosclerosis

Blood, 2004-07, Vol.104 (1), p.11-18

2004

Volltextzugriff (PDF)

Bacillus anthracis peptidoglycan activates human platelets through FcγRII and complement

Blood, 2013-07, Vol.122 (4), p.571-579

2013

Volltextzugriff (PDF)

A role for multidrug resistance protein 4 (MRP4; ABCC4) in human dendritic cell migration

Blood, 2008-09, Vol.112 (6), p.2353-2359

2008

Volltextzugriff (PDF)

Phase 3 study of the multidrug resistance modulator PSC-833 in previously untreated patients 60 years of age and older with acute myeloid leukemia: Cancer and Leukemia Group B Study 9720

Blood, 2002-08, Vol.100 (4), p.1224-1232

2002

Volltextzugriff (PDF)

Fibronectins are essential for heart and blood vessel morphogenesis but are dispensable for initial specification of precursor cells

Blood, 1997-10, Vol.90 (8), p.3073-3081

1997

Volltextzugriff (PDF)

Thrombospondin and fibrinogen bind serotonin-derivatized proteins on COAT-platelets

Blood, 2002-10, Vol.100 (8), p.2827-2831

2002

Volltextzugriff (PDF)

Postremission therapy in older patients with de novo acute myeloid leukemia: a randomized trial comparing mitoxantrone and intermediate-dose cytarabine with standard-dose cytarabine

Blood, 2001-08, Vol.98 (3), p.548-553

2001

Volltextzugriff (PDF)

A phase 1 study of imatinib for corticosteroid-dependent/refractory chronic graft-versus-host disease: response does not correlate with anti-PDGFRA antibodies

Blood, 2011-10, Vol.118 (15), p.4070-4078

2011

Volltextzugriff (PDF)

Sequential multiagent chemotherapy is not superior to high-dose cytarabine alone as postremission intensification therapy for acute myeloid leukemia in adults under 60 years of age: Cancer and Leukemia Group B Study 9222

Blood, 2005-05, Vol.105 (9), p.3420-3427

2005

Volltextzugriff (PDF)

Expression and activity of breast cancer resistance protein (BCRP) in de novo and relapsed acute myeloid leukemia

Blood, 2002-05, Vol.99 (10), p.3763-3770

2002

Volltextzugriff (PDF)

A randomized controlled trial of filgrastim during remission induction and consolidation chemotherapy for adults with acute lymphoblastic leukemia : CALGB study 9111

Blood, 1998-09, Vol.92 (5), p.1556-1564

1998

Volltextzugriff (PDF)

P-glycoprotein inhibition using valspodar (PSC-833) does not improve outcomes for patients younger than age 60 years with newly diagnosed acute myeloid leukemia: Cancer and Leukemia Group B study 19808

Blood, 2010-09, Vol.116 (9), p.1413-1421

2010

Volltextzugriff (PDF)

Results of a Phase 1/2 Study for KW-0761, a Monoclonal Antibody Directed Against CC Chemokine Receptor Type 4 (CCR4), In CTCL Patients

Blood, 2010-11, Vol.116 (21), p.962-962

2010

Volltextzugriff (PDF)

Individual patient data meta-analysis of randomized trials evaluating IL-2 monotherapy as remission maintenance therapy in acute myeloid leukemia

Blood, 2011-06, Vol.117 (26), p.7007-7013

2011

Volltextzugriff (PDF)

β2- Adrenergic Signaling Regulates Graft Versus Host Disease after Allogenic Transplantation While Preserving Graft Versus Leukemia Effect

Blood, 2019-11, Vol.134 (Supplement_1), p.1915-1915

2019

Volltextzugriff (PDF)

Prognostic importance of mutations in the ras proto-oncogenes in De Novo acute myeloid leukemia

Blood, 1994-03, Vol.83 (6), p.1603-1611

1994

Volltextzugriff (PDF)

Molecular basis of bortezomib resistance: proteasome subunit β5 (PSMB5) gene mutation and overexpression of PSMB5 protein

Blood, 2008-09, Vol.112 (6), p.2489-2499

2008

Volltextzugriff (PDF)

Age, Sex and Self-Reported Race Differences in Immune Profiles of Hematologic Malignancy Patients

Blood, 2021-11, Vol.138 (Supplement 1), p.4066-4066

2021

Volltextzugriff (PDF)

Impact of Molecular Features of Diffuse Large B-Cell Lymphoma on Treatment Outcomes with Anti-CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy

Blood, 2021-11, Vol.138 (Supplement 1), p.165-165

2021

Volltextzugriff (PDF)

Clinical Experience in the Randomized Phase 3 Sierra Trial: Anti-CD45 Iodine (131I) Apamistamab [Iomab-B] Conditioning Enables Hematopoietic Cell Transplantation with Successful Engraftment and Acceptable Safety in Patients with Active, Relapsed/Refractory AML Not Responding to Targeted Therapies

Blood, 2021-11, Vol.138 (Supplement 1), p.1791-1791

2021

Volltextzugriff (PDF)

1 – 25 von 694

Suche als RSS-Feed

Aktive Filter

SprachePortugiesisch

Zeitschrift / SerieBlood

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(694)
Mit Volltextzugriff
(693)

Publikationsform

Artikel
(694)

Sprache

Englisch
(694)
Japanisch
(98)

Erscheinungsjahr

n.n

Thema

Hematology
(316)
Life Sciences & Biomedicine
(310)
Science & Technology
(310)
Humans
(292)
Biological And Medical Sciences
(236)
Medical Sciences
(190)
Male
(117)
Female
(113)
Hematologic And Hematopoietic Diseases
(109)
Adult
(102)
Animals
(88)
Middle Aged
(86)
Adolescent
(60)
Mice
(60)
Child
(53)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(53)
Aged
(49)
Fundamental And Applied Biological Sciences. Psychology
(47)
Anesthesia. Intensive Care Medicine. Transfusions. Cell Therapy And Gene Therapy
(39)
Child, Preschool
(38)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Zeitschrift / Serie

Blood-The Journal Of Hematology
(6)

Menü

Weitere Dienste

Einstellungen

Extracellular histones promote thrombin generation through platelet-dependent mechanisms: involvement of platelet TLR2 and TLR4

Active tissue factor pathway inhibitor is expressed on the surface of coated platelets

Prophylactic rituximab after allogeneic transplantation decreases B-cell alloimmunity with low chronic GVHD incidence

Late acute graft-versus-host disease: a prospective analysis of clinical outcomes and circulating angiogenic factors

X-linked clonality testing: interpretation and limitations

Deletion of the alternatively spliced fibronectin EIIIA domain in mice reduces atherosclerosis

Bacillus anthracis peptidoglycan activates human platelets through FcγRII and complement

A role for multidrug resistance protein 4 (MRP4; ABCC4) in human dendritic cell migration

Phase 3 study of the multidrug resistance modulator PSC-833 in previously untreated patients 60 years of age and older with acute myeloid leukemia: Cancer and Leukemia Group B Study 9720

Fibronectins are essential for heart and blood vessel morphogenesis but are dispensable for initial specification of precursor cells

Thrombospondin and fibrinogen bind serotonin-derivatized proteins on COAT-platelets

Postremission therapy in older patients with de novo acute myeloid leukemia: a randomized trial comparing mitoxantrone and intermediate-dose cytarabine with standard-dose cytarabine

A phase 1 study of imatinib for corticosteroid-dependent/refractory chronic graft-versus-host disease: response does not correlate with anti-PDGFRA antibodies

Sequential multiagent chemotherapy is not superior to high-dose cytarabine alone as postremission intensification therapy for acute myeloid leukemia in adults under 60 years of age: Cancer and Leukemia Group B Study 9222

Expression and activity of breast cancer resistance protein (BCRP) in de novo and relapsed acute myeloid leukemia

A randomized controlled trial of filgrastim during remission induction and consolidation chemotherapy for adults with acute lymphoblastic leukemia : CALGB study 9111

P-glycoprotein inhibition using valspodar (PSC-833) does not improve outcomes for patients younger than age 60 years with newly diagnosed acute myeloid leukemia: Cancer and Leukemia Group B study 19808

Results of a Phase 1/2 Study for KW-0761, a Monoclonal Antibody Directed Against CC Chemokine Receptor Type 4 (CCR4), In CTCL Patients

Individual patient data meta-analysis of randomized trials evaluating IL-2 monotherapy as remission maintenance therapy in acute myeloid leukemia

β2- Adrenergic Signaling Regulates Graft Versus Host Disease after Allogenic Transplantation While Preserving Graft Versus Leukemia Effect

Prognostic importance of mutations in the ras proto-oncogenes in De Novo acute myeloid leukemia

Molecular basis of bortezomib resistance: proteasome subunit β5 (PSMB5) gene mutation and overexpression of PSMB5 protein

Age, Sex and Self-Reported Race Differences in Immune Profiles of Hematologic Malignancy Patients

Impact of Molecular Features of Diffuse Large B-Cell Lymphoma on Treatment Outcomes with Anti-CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy

Clinical Experience in the Randomized Phase 3 Sierra Trial: Anti-CD45 Iodine (131I) Apamistamab [Iomab-B] Conditioning Enables Hematopoietic Cell Transplantation with Successful Engraftment and Acceptable Safety in Patients with Active, Relapsed/Refractory AML Not Responding to Targeted Therapies

Aktive Filter

Suchergebnisse filtern